Seoul DNA vaccine developer, GeneOne Life Science joins with Inovio on Zika virus vaccine development
by Press Release from Outbreak News Today on (#11MKX)
Seoul, South Korea based DNA vaccine developer GeneOne Life Science yesterday announced the initiation of a collaborative research program with Inovio Pharmaceuticals to test and advance a DNA-based vaccine for preventing and treating the emerging and virulent Zika virus infection. Inovio and its collaborators are leveraging their past experience in designing and testing novel DNA-based vaccines for related ["]
